Clinical Study

Early Real-World Experience with CoreValve Evolut PRO and R Systems for Transcatheter Aortic Valve Replacement

Table 3

Device success at discharge.

Evolut PRO (N = 60)Evolut R (N = 56) value

Absence of procedural mortality60 (100)56 (100)1.00
Correct positioning of single valve in proper anatomical location60 (100)56 (100)1.00
Intended performance of prosthetic heart valve
No prosthesis-patient mismatch60 (100)56 (100)1.00
Mean gradient <20 mm Hg or peak velocity <3 m/s60 (100)55 (98)0.79
Absence of moderate or severe prosthetic regurgitation57 (95)50 (89)0.25
Overall device success54 (90.0)50 (89.3)0.90

Values are n (%).